Striving to be a global leader in medical products automation.
Founded in March 2003, Maider (Stock Code: 688310.SH) was listed on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange in December 2019, making it the first company from Taizhou to be listed on the STAR Market. The company specializes in the R&D, production, sales, and service of intelligent equipment for medical consumables. Leveraging years of technical expertise in precision manufacturing, Maider officially entered the ophthalmology field in 2022 as part of its strategic business expansion.
Maider brings together professionals across multiple disciplines—including mechanics, electronics, software, machine vision, and materials—to drive its R&D and manufacturing excellence. Several of its self-developed units have been honored as "National First Unit/Set" equipment. Since its inception, the company has delivered over 3,000 systemic solutions to hundreds of leading medical enterprises worldwide. Maider provides comprehensive technical support, from process development to validation, helping clients upgrade their manufacturing capabilities through the seamless synergy of equipment, software, and technology.
Our marketing network spans
more than 20 countries across the globe.
Maider was founded, entering the medical automation industry.
To support business growth and attract specialized talent, Maider relocated to Shenzhen, where it established an R&D center in Nanshan Science Park and built a dedicated engineering team.
In response to the Zhejiang government’s “Return of Zhejiang Entrepreneurs” initiative, Maider relocated to Yuhuan with its core technical team.
Phase I of the Maider Industrial Park was completed. The Flexible Medical Catheter Automated Assembly Line was named a National Key New Product, marking Maider’s entry into global markets.
Maider established the Zhejiang Provincial Enterprise Technology Center and the Zhejiang Provincial Key Enterprise Research Institute.
A subsidiary in Tianjin was also established.
Listed on the SSE STAR Market (688310); Phase II Industrial Park started; named a national SRDI “Little Giant” enterprise.
The Automated Spinning Line for Hollow Fiber Membranes for Hemodialysis has been put into mass production and has received the honor of being a 'First (Set) in China'.
Contact lens factory was established.
Maider celebrated its 20th anniversary and officially relocated to its Phase II facility. Its Automated Assembly Equipment for Insulin Pen Needles was also recognized as a “First-of-its-Kind” system in China.
Recognized as a National Green Factory and approved for a National Postdoctoral Research Workstation. New subsidiaries were established, and the 35,000-unit intelligent medical device expansion project progressed.
It takes dedication to achieve excellence in any field.
It takes dedication to achieve excellence in any field. While there may be countless opportunities and temptations in each period, a company can only achieve long-term survival and make a difference when it adopts a craftsmanship spirit of striving for the best.This embodies Maider's creed, "To do our utmost in our chosen field".
It is our reverence for technology and unwavering commitment to quality that have enabled Maider’s steady progress today.Today, as a leading enterprise in sub-industries, Maider has helped numerous clients implement intelligent manufacturing. It is my wish to witness the day when Maider facilitates the innovation and development of the entire industry in its own way.
I am well aware that we will fulfill the wish by rising to challenges, in spite of the fact that this journey is long and full of difficulties.
We will customize a solution to suit your needs!